Pedone: Two Micro-Cap Pharma Stocks Worth Watching

Loading...
Loading...

In this week’s email to subscribers, independent trader and technical analyst Roberto Pedone commented on a few interesting small and micro-cap stocks. Below is a look at two micro-cap biopharmaceutical stocks that he likes.

 

Anthera Pharmaceuticals

Anthera Pharmaceuticals Inc ANTH is a Delaware-based biopharmaceutical company with a “nice looking ascending triangle chart setup” that looks ready to trigger over $5.10, to $5.25 and then beyond $5.33, Pedone says.

As it can be seen, the stock is “making higher lows over the last three months and now it's bouncing off both its 50-day at $4.54 and its 20-day at $4.69.”

The analyst assures he would only play this if gets really robust volume, “since it's tried to break out a few times recently and failed.” Support looks solid around $4.60.

Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals Inc RCPI is a $17.1 million market cap pharmaceutical company that, according to Pedone, has a chance of becoming the next Cleveland BioLabs, Inc. CBLI.

“Chart and share structure gives it a chance, so be on high alert for this one if it gets volume and starts ripping,” the analyst says.

“I'm not 100% sure if Yahoo Finance has the float right for $RCPI at 7.3 million, but nonetheless the chart is primed. Over $2.03 and then its 20-day at $2.17 could set it off, so look for massive volume like $CBLI had on Tuesday,” he adds, concluding that this is a thin name, and one should only take it if he/she is comfortable trading these.

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorBiotechLong IdeasHealth CareTechnicalsAnalyst RatingsTrading IdeasGeneralRoberto Pedone
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...